Alzheimer's Disease (AD) is thought to involve early synapse loss. Familial AD is most often caused by mutations in presenilins, which are the catalytic subunits of g-secretase. Inactivation of g-secretase in adult mice by conditional deletion of its presenilin or nicastrin subunits causes synaptic impairments followed by neurodegeneration, but the relation of the loss of g-secretase acitivity, the observed synaptic impairments, and the neurodegeneration is unclear, as is the connection between these processes and human AD. The present project will focus on clarifying the synaptic function of g-secretase in mature neurons and its relation to neurodegeneration, using mice as a model system. The project proposes four specific aims to address this overall goal. The first two specific aims will mechanistically characterize the synaptic impairments that are caused by g-secretase inactivation in young adult mice in vivo, and analyze their relation to the neurodegeneration that develops at a later stage after g-secretase inactivation. The third and fourth specific aim will then test the hypothesis that at least some of the synaptic functions of g-secretase that are impaired upon its inactivation may be mediated by g-secretase-dependent cleavage of presynaptic neurexins and postsynaptic neuroligins, which are trans-synaptic cell-adhesion molecules that bind to each other and act as master regulators of synaptic properties. Strikingly in this context, neurexins and neuroligins were shown previously to be substrates for g-secretase, were genetically linked to AD, and are arguably the most plausible mediators of g-secretase function at the synapse. To test the involvement of neurexins and neuroligins in the synaptic functions of g-secretase, the project will characterize the site and regulation of the g-secretase- dependent cleavage of neurexins and neuroligins, and probe the function of this cleavage using conditional knockout mice of these molecules. Moreover, the project will examine whether inactivation of neurexin- and/or neuroligin-cleavage promotes neurodegeneration. Viewed together, the experiments of this project will thus not only characterize the synaptic function of g-secretase and its relation to neurodegeneration, but also determine whether the synaptic function of g-secretase involves the cleavage of neurexins and/or neuroligins and whether such cleavage may play a contributory role in the pathogenesis of AD.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
1P50AG047366-01A1
Application #
8849317
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2015-07-01
Budget End
2016-04-30
Support Year
1
Fiscal Year
2015
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94304
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Kim, Jeehyun; Zhang, Kai; Cai, Weidong et al. (2018) Dopamine-related dissociation of cortical and subcortical brain activations in cognitively unimpaired Parkinson's disease patients OFF and ON medications. Neuropsychologia 119:24-33
Qian, Winnie; Fischer, Corinne E; Schweizer, Tom A et al. (2018) Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease. Curr Alzheimer Res 15:187-194
Gallagher, Damien; Kiss, Alex; Lanctot, Krista et al. (2018) Depression and Risk of Alzheimer Dementia: A Longitudinal Analysis to Determine Predictors of Increased Risk among Older Adults with Depression. Am J Geriatr Psychiatry 26:819-827
Haaksma, Miriam L; Calderón-Larrañaga, Amaia; Olde Rikkert, Marcel G M et al. (2018) Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes. Int J Geriatr Psychiatry 33:1057-1064
Smith, Alexander K; Periyakoil, Vyjeyanthi S (2018) Should We Bury ""The Good Death""? J Am Geriatr Soc 66:856-858
Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10
Hadjichrysanthou, Christoforos; McRae-McKee, Kevin; Evans, Stephanie et al. (2018) Potential Factors Associated with Cognitive Improvement of Individuals Diagnosed with Mild Cognitive Impairment or Dementia in Longitudinal Studies. J Alzheimers Dis 66:587-600
Hanfelt, John J; Peng, Limin; Goldstein, Felicia C et al. (2018) Latent classes of mild cognitive impairment are associated with clinical outcomes and neuropathology: Analysis of data from the National Alzheimer's Coordinating Center. Neurobiol Dis 117:62-71
Burke, Shanna L; Hu, Tianyan; Fava, Nicole M et al. (2018) Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities. J Women Aging :1-25

Showing the most recent 10 out of 117 publications